Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
1.
Clin Infect Dis ; 47(4): 487-95, 2008 Aug 15.
Article in English | MEDLINE | ID: mdl-18636955

ABSTRACT

BACKGROUND: Resistance to commonly used antituberculosis drugs is emerging worldwide. Conventional drug-susceptibility testing (DST) methods are slow and demanding. Alternative, rapid DST methods would permit the early detection of drug resistance and, in turn, arrest tuberculosis transmission. METHODS: A cost-effectiveness analysis of 5 DST methods was performed in the context of a clinical trial that compared rapid with conventional DST methods. The methods under investigation were direct phage-replication assay (FASTPlaque-Response; Biotech), direct amplification and reverse hybridization of the rpoB gene (INNO-LiPA; Innogenetics), indirect colorimetric minimum inhibitory concentration assay (MTT; ICN Biomedicals), and direct proportion method on Löwenstein-Jensen medium. These were compared with the widely used indirect proportion method on Löwenstein-Jensen medium. RESULTS: All alternative DST methods were found to be cost-effective, compared with other health care interventions. DST methods also generate substantial cost savings in settings of high prevalence of multidrug-resistant tuberculosis. Excluding the effects of transmission, the direct proportion method on Löwenstein-Jensen medium was the most cost-effective alternative DST method for patient groups with prevalences of multidrug-resistant tuberculosis of 2%, 5%, 20%, and 50% (cost in US$2004, $94, $36, $8, and $2 per disability-adjusted life year, respectively). CONCLUSION: Alternative, rapid methods for DST are cost-effective and should be considered for use by national tuberculosis programs in middle-income countries.


Subject(s)
Antitubercular Agents/pharmacology , Drug Resistance, Multiple, Bacterial , Mycobacterium tuberculosis/drug effects , Tuberculosis, Multidrug-Resistant/diagnosis , Bacterial Proteins/genetics , Colorimetry , Cost-Benefit Analysis , DNA-Directed RNA Polymerases , Gene Amplification , Humans , Income/classification , Microbial Sensitivity Tests/economics , Microbial Sensitivity Tests/methods , Mycobacteriophages/physiology , Mycobacterium tuberculosis/genetics , Mycobacterium tuberculosis/growth & development , Nucleic Acid Hybridization , Peru , Quality-Adjusted Life Years , Reagent Kits, Diagnostic , Sensitivity and Specificity , Time Factors , Tuberculosis, Multidrug-Resistant/epidemiology , Tuberculosis, Multidrug-Resistant/microbiology , Tuberculosis, Pulmonary/diagnosis , Tuberculosis, Pulmonary/epidemiology , Tuberculosis, Pulmonary/microbiology
3.
Int. j. lepr. other mycobact. dis ; 65(2): 203-210, Jun. 1997. tab, graf
Article in English | Sec. Est. Saúde SP, HANSEN, Hanseníase Leprosy, SESSP-ILSLACERVO, Sec. Est. Saúde SP | ID: biblio-1226673

ABSTRACT

SETTING: An epidemiological study of the interaction of leprosy and HIV infection in Tanzania. OBJECTIVE: To establish the prevalence of HIV infection among leprosy patients, and to measure the association of HIV and leprosy by comparing the HIV prevalence in leprosy patients and blood donors. DESIGN: Testing for HIV infection in consecutively diagnosed leprosy patients (new and relapsed after MDT) in all regions in Tanzania successively for a period of 3 to 6 months during 1991, 1992 and 1993. RESULTS: Out of the total estimated eligible leprosy patients, 697 patients (69%) entered the final analysis. The HIV prevalence among these leprosy patients was 12% (83/697) as compared to 6% (8960/ 158,971) in blood donors examined in Tanzania during the same period. There were no significant differences in HIV seroprevalence by age, sex, residence or type of disease. However, the adjusted odds ratio (OR) of the presence of a BCG scar was 1.9 [95% confidence interval (CI) 1.1-3.3] among HIV-positive leprosy cases compared to HIV-negative leprosy cases. Comparing leprosy cases with blood donors as controls, the logistic regression model, controlling for sex, age group and residence, showed the OR for HIV seropositivity among leprosy patients to be 2.5 (95% CI 2.0-3.2). This association existed in all strata, but was strongest in the 15-34-year age group. No difference of HIV status between multibacillary and paucibacillary leprosy could be shown to exist. The point estimate of the population attributable risk of HIV infection for leprosy was 7%. CONCLUSION: HIV infection is associated with leprosy and might reverse the epidemiological trend of the slow decline in case notification in Tanzania if HIV infection is increasing greatly. Previous BCG vaccination loses its protection against leprosy in the presence of HIV infection. A repeated study is recommended in order to validate these findings, whereby recording of the disability grading of the cases is necessary to adjust for delay in diagnosis.


Subject(s)
Male , Female , Humans , Adolescent , Adult , HIV Antibodies/analysis , Leprosy/complications , Leprosy/epidemiology , HIV Infections/complications , HIV Infections/epidemiology
4.
MX, DF; Interamericana; 4a ed.; 1985. 293 p.
Monography in Spanish | URUGUAIODONTO | ID: odn-1780

Subject(s)
Radiology , Dentistry
5.
MX, DF; Interamericana; 2a ed.; 1975. 216 p.
Monography in Spanish | URUGUAIODONTO | ID: odn-1415

Subject(s)
Radiology , Dentistry
6.
Article | PAHO-IRIS | ID: phr-16164

ABSTRACT

Los estudios efectuados señalan que los desplazamientos antigénicos en el virus A de influenza aparecen según un ciclo que se repite y se va renovando. En 1973 se diagnosticó la reaparición de la cepa de influenza porcina aislada en Fort Dix, Nueva Jersey, similar a que desató la pandemia de 1918 (AU)


Subject(s)
Influenza A virus , Epidemiology , United States
SELECTION OF CITATIONS
SEARCH DETAIL